Opendata, web and dolomites

LiVirIn

3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiVirIn project word cloud

Explore the words cloud of the LiVirIn project. It provides you a very rough idea of what is the project "LiVirIn" about.

train    organoids    hepatocytes    annually    engineering    risk    an    industry    disseminated    industries    safe    hepatocyte    pharmaceutical    particles    reactivation    model    biophysics    pluripotent    people    hypothesis    evaluation    hypothesize    efficacy    endothelial    encompassing    wages    international    infection    biochemical    superior    creation    stem    delivers    publications    drugs    eradicate    thinker    meetings    models    prevented    networking    vitro    suppression    inexhaustible    interdisciplinary    circular    source    closed    disease    expertise    biophysical    hepatic    immune    658    peer    chemotherapy    potent    million    boost    completely    chronically    tropism    lack    knowledgeable    biology    researcher    human    worldwide    3d    ing    dna    nucleus    medical    mobility    replication    lost    maturation    appropriate    vaccination    400    mimics    carrier    stable    enormous    pscs    causing    covalently    animal    hampered    hbv    narrow    infected    function    sinusoidal    form    inter    life    academia    cure    conferences    transfer    cells    presentations    viral    cccdna    independent    lsecs    clinically    strategies    hepatitis    antiviral    hscs    liver    culture    stellate    scientific    virus    matrix   

Project "LiVirIn" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.kuleuven.be/samenwerking/scil/about_us/livirin
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 172˙800.00

Map

 Project objective

An estimated ~400 million people are chronically infected with hepatitis B virus (HBV) infection worldwide, resulting in an estimated $658 million in medical costs and lost wages annually. Although HBV disease can be prevented by vaccination, many people still become infected. Potent and safe drugs are available to eradicate HBV viral particles and clinically ‘cure’ HBV infection. However, during replication HBV delivers a very stable form of viral DNA (covalently closed circular DNA, cccDNA) in the nucleus of the hepatocyte, causing life-long risk of reactivation of HBV infection in case of suppression of the immune system (e.g. chemotherapy). Therefore the pharmaceutical industry is now aiming to develop strategies to eradicate the virus from the infected liver completely. Such studies are hampered by the lack of appropriate in vitro or animal models due to the narrow tropism of HBV for human hepatocytes. The hypothesis of the project is that creation of 3D culture systems encompassing hepatocytes, hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs) derived from an inexhaustible source of cells (human pluripotent stem cells (PSCs)) in a matrix that mimics the biophysical and biochemical features of the liver, will be a superior model for the study of HBV infection and evaluation of the efficacy of antiviral drugs. We also hypothesize that such 3D organoids will improve maturation and function of hepatocytes, HSCs and LSECs. The proposed studies are highly interdisciplinary, merging expertise from biology, to biophysics and engineering, with inter-sector mobility, networking, collaboration and knowledge transfer between academia and industries. The knowledge developed will be disseminated by presentations at consortium meetings, international conferences and in peer publications. All these aspects will train the researcher as independent thinker, more knowledgeable in scientific research which will provide an enormous boost to his carrier.

 Publications

year authors and title journal last update
List of publications.
2016 M. Kumar, G. Rustandi, R. Boon, R. S. Patil, P. Roelandt, C. Verfaillie;
2016 TERMIS - Americas Conference and Exhibition San Diego, CA December 11–14, 2016
published pages: S-1-S-156, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2016.5000.abstracts
Tissue Engineering Part A 22/S1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVIRIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVIRIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LearningEmotions (2020)

Emotion Recognition: A Statistical Learning Approach

Read More  

TOPOCIRCUS (2019)

Simulations of Topological Phases in Superconducting Circuits

Read More  

BIOplasma (2019)

Use flexible Tube Micro Plasma (FµTP) for Lipidomics

Read More